[Simultaneous cholinergic and intermediate syndromes in organophosphate poisoning].
M
M
Delgado
I
I
Catalán
J
J
Masclans
A
A
Mas
D000368:Aged; D001919:Bradycardia / Q000139:chemically induced*; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002801:Cholinesterase Reactivators / Q000627:therapeutic use; D002802:Cholinesterases / Q000097:blood; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D017809:Fatal Outcome; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D062025:Organophosphate Poisoning; D011041:Poisoning / Q000175:diagnosis; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000175:diagnosis; D012121:Respiration, Artificial; D012133:Respiratory Paralysis / Q000139:chemically induced*; D013577:Syndrome
D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; D002802:Cholinesterases; C028797:pralidoxime
Síndrome colinérgico y síndrome intermedio confluyentes en una intoxicación por organofosforados.